✦ LIBER ✦

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

✍ Scribed by M. Rodriguez-Torres; E. Lawitz; B. Conway; K. Kaita; A.M. Sheikh; R. Ghalib; R. Adrover; C. Cooper; M. Silva; M. Rosario; B. Bourgault; L. Proulx; J.G. McHutchison

Book ID: 117378119
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 53 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60033-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

92 SAFETY, TOLERABILITY AND ANTIVIRAL AC

92 SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF VCH-916, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION

✍ E. Lawitz; C. Cooper; M. Rodriguez-Torres; R. Ghalib; R. Lalonde; A. Sheikh; B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLE

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV

✍ S.A. Villano; D. Raible; D. Harper; J. Speth; P. Chandra; P. Shaw; G. Bichier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Safety and Antiviral Activity of the HCV

Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study

✍ Sulkowski, M. S.; Kang, M.; Matining, R.; Wyles, D.; Johnson, V. A.; Morse, G. D 📂 Article 📅 2013 🏛 University of Chicago Press 🌐 English ⚖ 338 KB

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SA

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

✍ M. Manns; H. Reesink; C. Moreno; T. Berg; Y. Benhamou; Y. Horsmans; G. Dusheiko; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

940 SAFETY, TOLERABILITY AND PHARMACOKIN

940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS

✍ C. Cooper; R. Larouche; B. Bourgault; N. Chauret; L. Proulx 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

1184 CHARACTERIZATION OF HCV VARIANTS IN

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

✍ Zhang, E.Z.; Tigges, A.; Jiang, M.; Dorrian, J.; Spanks, J.; Ardzinski, A.; Alve 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB